Back to search
FDAFDA · Food and drugs·Recall number D-0129-2023

Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.25%, 25 mg per 10 mL (2.5 mg per mL), 10 mL Single Dose Vial (NDC 63323-468-01), packaged in 25 Single Dose Vials per tray (NDC 63323-468-17), Rx only, Fresenius Kabi, Lake Zurich, IL 60047.

Published January 25, 2023 · Recall initiated: November 22, 2022

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
SENSORCAINE
Manufacturer
Fresenius Kabi USA, LLC
Distributor
Nationwide in the USA
UPC
0363323472030
Lot
Batch #: 6128800, exp 12/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card